Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
By:
Johnson & Johnson via
Business Wire
February 12, 2024 at 16:10 PM EST
Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/
Contacts
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
More News
View More
2 Stocks to Avoid as Crypto Momentum Wanes ↗
December 21, 2025
Via MarketBeat
3 Dividend Growth Stocks Analysts Are Upgrading for 2026 ↗
December 21, 2025
Via MarketBeat
These 3 Banks Are Rallying Into Year-End, But Will It Continue? ↗
December 20, 2025
Via MarketBeat
This ETF Caught a Major Tailwind After the Fed’s Rate Cut ↗
December 20, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>